Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis

Objective: To identify predictors of clinical disease activity after treatment change to higher-dose interferon beta-1a in relapsing-remitting multiple sclerosis (MS). Methods: This was a retrospective-prospective observational multicenter study. We enrolled patients with at least one relapse on pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Novotna, Martina, Tvaroh, Ales, Mares, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492204/
https://www.ncbi.nlm.nih.gov/pubmed/32982947
http://dx.doi.org/10.3389/fneur.2020.00944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492204/
https://www.ncbi.nlm.nih.gov/pubmed/32982947
http://dx.doi.org/10.3389/fneur.2020.00944

Ejemplares similares